| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
48 |
| Employees |
14 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-222 |
| Cash Flow (TTM) (Millions $) |
-46 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Cargo Therapeutics Inc is a biotechnology company that specializes in developing novel therapies based on the use of engineered exosomes. Exosomes are small vesicles that are naturally produced by cells and are responsible for the transportation of molecules within the body.
Cargo Therapeutics has developed a proprietary technology platform that allows them to engineer exosomes to carry therapeutic cargo, such as drugs or genetic material, to specific cells or tissues in the body. This targeted delivery system has the potential to improve the effectiveness and safety of various therapies, including those for cancer, genetic diseases, and inflammatory conditions.
The company’s technology is based on cutting-edge research in the field of exosome biology and utilizes advanced techniques in genetic engineering and nanoparticle engineering. Cargo Therapeutics is focused on leveraging this technology to develop innovative therapies that address significant unmet medical needs and improve patient outcomes.
Overall, Cargo Therapeutics aims to revolutionize the field of therapeutics by harnessing the natural transport capabilities of exosomes to deliver therapeutics precisely where they are needed in the body.
Company Address: 835 Industrial Road San Carlos 94070 CA
Company Phone Number: 499-8950 Stock Exchange / Ticker: NASDAQ CRGX
|
%
3.3% 